Dale Ando earns prestigious FDA appointment

Dale Ando M.D., Vice President Therapeutic Development and Chief Medical Officer of Sangamo BioSciences (SGMO) has been appointed to the Cellular, Tissue and Gene Therapies Advisory Committee of the FDA. His term runs from 4/1/2015 to 3/31/2019. His area of expertise is Industry Representative.